2-bromo-N-(3-(4-(3-ethynylphenylamino)-6,7-dimethoxy quinazolin-2-ylamino)phenyl)-4-(trifluoromethyl)benzenesulfonamide | 1581248-50-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-bromo-N-(3-(4-(3-ethynylphenylamino)-6,7-dimethoxy quinazolin-2-ylamino)phenyl)-4-(trifluoromethyl)benzenesulfonamide
• 英文别名: 2-bromo-N-[3-[[4-(3-ethynylanilino)-6,7-dimethoxyquinazolin-2-yl]amino]phenyl]-4-(trifluoromethyl)benzenesulfonamide
• CAS: 1581248-50-1
• 化学式: C₃₁H₂₃BrF₃N₅O₄S
• 分子量: 698.52
• InChiKey: TXWSWIGFWFNLAR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  45
• 可旋转键数：
  10
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  123
• 氢给体数：
  3
• 氢受体数：
  12

文献信息

• ARYL AMINE SUBSTITUTED PYRIMIDINE AND QUINAZOLINE AND THEIR USE AS ANTICANER DRUGS
  申请人：National Taiwan University

  公开号：US20140080848A1

  公开（公告）日：2014-03-20

  A series of mono- and di-substituted quinazoline and pyrimidine derivatives based on the skeleton of erlotinib (an EGFR inhibitor) were synthesized and their bioactivities against hepatocellular carcinoma and human lung adenocarcinoma were evaluated.

  基于厄洛替尼（一种EGFR抑制剂）骨架合成了一系列单取代和双取代的喹唑啉和嘧啶衍生物，并评估了它们对肝细胞癌和人类肺腺癌的生物活性。
• ARYL AMINE SUBSTITUTED PYRIMIDINE AND QUINAZOLINE AND THEIR USE AS ANTICANCER DRUGS
  申请人：National Yang-Ming University

  公开号：US20150246891A1

  公开（公告）日：2015-09-03

  A series of mono- and di-substituted quinazoline and pyrimidine derivatives based on the skeleton of erlotinib (an EGFR inhibitor) were synthesized and their bioactivities against hepatocellular carcinoma and human lung adenocarcinoma were evaluated.
• US9394261B2
  申请人：——

  公开号：US9394261B2

  公开（公告）日：2016-07-19